Biotech Merger Under Fire

Minutes before signing a $4.2B merger between Helios Pharma and Nexus Biotech, you receive an encrypted email from Dr. Sarah Chen - your lead researcher. She threatens to release evidence of manipulated trial data for NX-2049, your breakthrough cancer drug. With 15 minutes until the signing ceremony and investors flooding the building, you must contain this crisis.

Challenges

Survivors

Popularity

Difficulty

B1-B2

Start Practicing Now

Scenario Overview

Your Role

Dr. James Morrison, CEO of Helios Pharma

Conversation Partner

Marcus Sterling, Board Chairman

Setting

Executive suite corner office, 47th floor, floor-to-ceiling windows showing a stormy Manhattan skyline

Location

Helios Pharma Global HQ, Manhattan

Learning Objectives

✓

Neutralize the whistleblower threat without creating evidence of wrongdoing

✓

Maintain merger timeline and investor confidence

✓

Protect personal position and company reputation

About This Scenario

How It Starts

“Morrison, cut the pleasantries. Chen's email just hit my phone too. You have exactly 15 minutes to make this disappear, or I'm calling an emergency board meeting to discuss your... future. What's your plan?”

This is how Marcus Sterling, Board Chairman's greeting will start.

Practice Details

Scenario ID

#427

What You'll Get

🎯Real-world conversation practice
🤖AI-powered speaking partner
📊Instant feedback on your performance
🎓Learn from your mistakes

Other Scenarios to Explore

Similar scenarios coming soon

Ready to Practice?

Start your speaking journey with BoldSpeak today. Sign up for free and get unlimited access to scenarios.

Get Started Free